Dr. Babatunde Ojofeitimi is a pharmacist who is specialized in Pharmacotherapy in Gainesville, Florida. Patients can reach him at 1601 Sw Archer Rd, Gainesville or contact him on 352-376-1611. Active license number of Dr. Babatunde Ojofeitimi is 0202205419 for Pharmacotherapy in Virginia. Dr. Babatunde Ojofeitimi is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Babatunde Ojofeitimi speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Babatunde Ojofeitimi are as mentioned below.
NPI Number:
1295827509
NPI Enumeration Date:
28 Sep, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Babatunde Ojofeitimi are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
0202205419
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1601 Sw Archer Rd, Gainesville, Florida
Zip:
32608-1135
Phone Number:
352-376-1611
Fax Number:
352-271-4565
Patients can reach Dr. Babatunde Ojofeitimi at 1601 Sw Archer Rd, Gainesville, Florida or can call on phone at 352-376-1611.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.